Related references
Note: Only part of the references are listed.Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry
Lisa J. Vermij et al.
BRITISH JOURNAL OF CANCER (2023)
Variation in practice in endometrial cancer and potential for improved care and equity through molecular classification
Amy Jamieson et al.
GYNECOLOGIC ONCOLOGY (2022)
Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer
Bob T. Li et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Genomic landscape of endometrial carcinomas of no specific molecular profile
Amir Momeni-Boroujeni et al.
MODERN PATHOLOGY (2022)
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer
J. Cortes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Microsatellite Instability-High Endometrial Cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles
Beryl L. Manning-Geist et al.
CLINICAL CANCER RESEARCH (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Clinicopathologic and Genomic Analysis of TP53-Mutated Endometrial Carcinomas
Amir Momeni-Boroujeni et al.
CLINICAL CANCER RESEARCH (2021)
Genetic and molecular subtype heterogeneity in newly diagnosed early-and advanced-stage endometrial cancer
Arnaud Da Cruz Paula et al.
GYNECOLOGIC ONCOLOGY (2021)
Incorporation of molecular characteristics into endometrial cancer management
Lisa Vermij et al.
HISTOPATHOLOGY (2020)
p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies
Naveena Singh et al.
JOURNAL OF PATHOLOGY (2020)
Interpretation of somatic POLE mutations in endometrial carcinoma
Alicia Leon-Castillo et al.
JOURNAL OF PATHOLOGY (2020)
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer
Kohei Shitara et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Natural Language Processing to Ascertain Cancer Outcomes From Medical Oncologist Notes
Kenneth L. Kehl et al.
JCO CLINICAL CANCER INFORMATICS (2020)
The Association and Significance of p53 in Gynecologic Cancers: The Potential of Targeted Therapy
Mitsuhiro Nakamura et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups
Tjalling Bosse et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series
S. Kommoss et al.
ANNALS OF ONCOLOGY (2018)
An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer
Casey M. Cosgrove et al.
GYNECOLOGIC ONCOLOGY (2018)
Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu
Amanda N. Fader et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Evolving Roles of Histologic Evaluation and Molecular/Genomic Profiling in the Management of Endometrial Cancer
Rajmohan Murali et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer
Malachi Griffith et al.
NATURE GENETICS (2017)
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Ahmet Zehir et al.
NATURE MEDICINE (2017)
Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma
Jeroen Depreeuw et al.
CLINICAL CANCER RESEARCH (2017)
Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts
Ellen Stelloo et al.
CLINICAL CANCER RESEARCH (2016)
Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatment
Aline Talhouk et al.
GYNECOLOGIC ONCOLOGY (2016)
A clinically applicable molecular-based classification for endometrial cancers
A. Talhouk et al.
BRITISH JOURNAL OF CANCER (2015)
Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT) A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology
Donavan T. Cheng et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2015)
Classification of endometrial carcinoma: more than two types
Rajmohan Murali et al.
LANCET ONCOLOGY (2014)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
Molecular, pathologic, and clinical features of early-onset endometrial cancer: Identifying presumptive lynch syndrome patients
Michael D. Walsh et al.
CLINICAL CANCER RESEARCH (2008)
Utility of immunohistochemistry in predicting microsatellite instability in endometrial carcinoma
Ippolito Modica et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)